Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$397K Buy
+750
New +$346K ﹤0.01% 1096
2023
Q4
Sell
-1,300
Closed -$315K 1133
2023
Q3
$315K Hold
1,300
﹤0.01% 962
2023
Q2
$312K Hold
1,300
﹤0.01% 969
2023
Q1
$244K Hold
1,300
﹤0.01% 1014
2022
Q4
$276K Hold
1,300
﹤0.01% 1025
2022
Q3
$204K Buy
+1,300
New +$207K ﹤0.01% 1152
2022
Q1
Sell
-1,100
Closed -$239K 1443
2021
Q4
$239K Hold
1,100
﹤0.01% 1243
2021
Q3
$208K Sell
1,100
-600
-35% -$109K ﹤0.01% 1244
2021
Q2
$300K Hold
1,700
﹤0.01% 1154
2021
Q1
$279K Buy
+1,700
New +$260K ﹤0.01% 1150

Other funds holding MEDP

Gabelli Funds's MEDP Position: Q2 2026 in Review

Gabelli Funds opened a new position in Medpace (MEDP) in Q2 2026: 750 shares worth $397K. The stake represents ﹤0.01% of the portfolio and ranks #1096 among its holdings. This is a return to the name: Gabelli Funds previously reported a position in MEDP as recently as Q3 2023.

Gabelli Funds first reported a position in MEDP in Q1 2021 and has held it in 10 quarters since. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Gabelli Funds held 750 shares of Medpace worth $397K as of Q2 2026.
  • Medpace was a new Gabelli Funds position in Q2 2026.
  • Medpace made up ﹤0.01% of Gabelli Funds's portfolio in Q2 2026, its #1096 holding.
  • Gabelli Funds first reported a position in Medpace in Q1 2021 and has held it in 10 quarters since.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.